IMRX
insider transactionsImmuneering Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 5 different insiders made open-market purchases in the last 365 days, totalling $259.4K.
Net shares · 365d
+57.9K
57.9K buy · 0 sell
Net value · 365d
$259.4K
$259.4K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
6
57.9K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
CHIEF SCIENTIFIC OFFICER
$25.0K
6.0K sh · $4.15
Own +2%
-
Grant·A
Director
$0
33.4K sh
Own New
-
Grant·A
Director
$0
33.4K sh
Own New
-
Grant·A
Director
$0
33.4K sh
Own New
-
Grant·A
Director
$0
33.4K sh
Own New
-
Grant·A
Director
$0
33.4K sh
Own New
-
Grant·A
CHIEF PEOPLE OFFICER
$15.6K
3.6K sh · $4.29
Own +14%
-
Grant·A
Chief Medical Officer
$0
140.0K sh
Own New
-
Grant·A
SVP Finance, CAO
$0
140.0K sh
Own New
-
Grant·A
CHIEF PEOPLE OFFICER
$0
140.0K sh
Own New
-
Grant·A
PRESIDENT AND CEO
$0
688.0K sh
Own New
-
Grant·A
CHIEF SCIENTIFIC OFFICER
$0
344.0K sh
Own New
-
Grant·A
Chief Business Officer
$0
140.0K sh
Own New
-
Grant·A
CHIEF LEGAL OFFICER, SECRETARY
$0
176.0K sh
Own New
-
Buy·P
Chief Business Officer
$25.0K
5.2K sh · $4.76
Own +91%
-
Buy·P
CHIEF SCIENTIFIC OFFICER
$10.5K
2.3K sh · $4.57
Own +1%
-
Buy·P
Director
$101.0K
21.6K sh · $4.67
Own +41%
-
Buy·P
CHIEF PEOPLE OFFICER
$10.9K
2.6K sh · $4.15
Own +11%
-
Buy·P
Director
$86.9K
20.0K sh · $4.35
Own +17%
-
Grant·A
Director
$0
7.9K sh
Own New
-
Grant·A
Director
$0
7.9K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Brett Matthew Hall | Buy P | 6.0K | $25.0K |
| Jun 11, 2026 | Thomas J. Schall | Grant A | 33.4K | $0 |
| Jun 11, 2026 | Laurie Keating | Grant A | 33.4K | $0 |
| Jun 11, 2026 | Diana Hausman | Grant A | 33.4K | $0 |
| Jun 11, 2026 | Peter Feinberg | Grant A | 33.4K | $0 |
| Jun 11, 2026 | CARPENTER ROBERT J | Grant A | 33.4K | $0 |
| Mar 13, 2026 | Leah R Neufeld | Grant A | 3.6K | $15.6K |
| Feb 3, 2026 | Igor Matushansky | Grant A | 140.0K | $0 |
| Feb 3, 2026 | Mallory Morales | Grant A | 140.0K | $0 |
| Feb 3, 2026 | Leah R Neufeld | Grant A | 140.0K | $0 |
| Feb 3, 2026 | Benjamin J. Zeskind KEY | Grant A | 688.0K | $0 |
| Feb 3, 2026 | Brett Matthew Hall | Grant A | 344.0K | $0 |
| Feb 3, 2026 | Harold Eugene Brakewood | Grant A | 140.0K | $0 |
| Feb 3, 2026 | Michael Bookman | Grant A | 176.0K | $0 |
| Jan 16, 2026 | Harold Eugene Brakewood | Buy P | 5.2K | $25.0K |
| Jan 15, 2026 | Brett Matthew Hall | Buy P | 2.3K | $10.5K |
| Jan 15, 2026 | Thomas J. Schall | Buy P | 21.6K | $101.0K |
| Jan 13, 2026 | Leah R Neufeld | Buy P | 2.6K | $10.9K |
| Jan 12, 2026 | Peter Feinberg | Buy P | 20.0K | $86.9K |
| Jan 1, 2026 | Laurie Keating | Grant A | 7.9K | $0 |
| Jan 1, 2026 | Peter Feinberg | Grant A | 7.9K | $0 |
About IMRX insider trading
This page tracks insider transactions for Immuneering Corp (IMRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.